Veterinary Medicines

Vitamine k 10 mg/ml pro inj., oplossing voor injectie.

Authorised
  • Menadione sodium bisulfite
Download as PDF

Product identification

Medicine name:
Vitamine k 10 mg/ml pro inj., oplossing voor injectie.
Active substance:
  • Menadione sodium bisulfite
Target species:
  • Cattle
  • Cattle (calf)
  • Horse
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Menadione sodium bisulfite
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
  • Intravenous use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB02BA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 2118
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/02/2022
Download